{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:40:34Z","timestamp":1787010034549,"version":"build-2736575974"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Severe acute malnutrition (SAM) may alter the pharmacokinetics (PK), efficacy, and safety of antiretroviral therapy. The phase IV study, IMPAACT P1092, compared PK, safety, and tolerability of zidovudine (ZDV), lamivudine (3TC), and lopinavir\/ritonavir (LPV\/r) in children with and without SAM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods:<\/jats:title>\n                    <jats:p>\n                      Children living with HIV 6 to &lt;36 months of age with or without World Health Organization (WHO)-defined SAM received ZDV, 3TC, and LPV\/r syrup for 48 weeks according to WHO weight band dosing. Intensive PK sampling was performed at weeks 1, 12, and 24. Plasma drug concentrations were measured using liquid chromatography tandem mass spectrometry. Steady-state mean area under the curve (AUC\n                      <jats:sub>0\u201312h<\/jats:sub>\n                      ) and clearance (CL\/F) for each drug were compared. Grade \u22653 adverse events were compared between cohorts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Fifty-two children were enrolled across 5 sites in Africa with 44% (23\/52) female, median age 19 months (Q1, Q3: 13, 25). Twenty-five children had SAM with entry median weight-for-height Z-score (WHZ) \u22123.4 (IQR \u22124.0, \u22123.0) and 27 non-SAM had median WHZ \u22121.0 (IQR \u22121.8, \u22120.1). No significant differences in mean AUC\n                      <jats:sub>0\u201312h<\/jats:sub>\n                      or CL\/F were observed (\n                      <jats:italic toggle=\"yes\">P\u2009<\/jats:italic>\n                      \u2265\n                      <jats:italic toggle=\"yes\">\u2009<\/jats:italic>\n                      0.09) except for lower 3TC AUC\n                      <jats:sub>0\u201312h<\/jats:sub>\n                      (GMR, 0.60; 95% CI, 0.4\u20131.0;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u20090.047) at week 12, higher ZDV AUC\n                      <jats:sub>0\u201312h<\/jats:sub>\n                      (GMR, 1.52; 1.2\u20132.0;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u20090.003) at week 24 in the SAM cohort compared with non-SAM cohort. Treatment-related grade \u22653 events did not differ significantly between cohorts (24.0% vs. 25.9%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>PK and safety findings for ZDV, 3TC, and LPV\/r support current WHO weight band dosing of syrup formulations in children with SAM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000003055","type":"journal-article","created":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T02:06:35Z","timestamp":1610762795000},"page":"446-452","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Pharmacokinetics and Safety of Zidovudine, Lamivudine, and Lopinavir\/Ritonavir in HIV-infected Children With Severe Acute Malnutrition in Sub-Saharan Africa: IMPAACT Protocol P1092"],"prefix":"10.1097","volume":"40","author":[{"given":"Maxensia","family":"Owor","sequence":"first","affiliation":[{"name":"Makerere University\u2014Johns Hopkins University Research Collaboration, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camlin","family":"Tierney","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Center for Biostatistics in AIDS Research, Harvard T.H Chan School of Public Health, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Ziemba","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Center for Biostatistics in AIDS Research, Harvard T.H Chan School of Public Health, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Browning","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Moye","sequence":"additional","affiliation":[{"name":"NIH\/NICHD\/DER\/MPIDB, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobbie","family":"Graham","sequence":"additional","affiliation":[{"name":"Frontier Science Foundation, Amherst, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Reding","sequence":"additional","affiliation":[{"name":"Frontier Science Foundation, Amherst, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Costello","sequence":"additional","affiliation":[{"name":"IMPAACT Laboratory Center, University of California, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Norman","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubbe","family":"Wiesner","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Hughes","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan E.","family":"Whalen","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette","family":"Purdue","sequence":"additional","affiliation":[{"name":"NIH\/NIAID\/DAIDS\/PAB, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blandina Theophil","family":"Mmbaga","sequence":"additional","affiliation":[{"name":"Kilimanjaro Clinical Research Institute\u2014Kilimanjaro Christian Medical Center and Kilimanjaro Christian Medical University College, Moshi, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Portia","family":"Kamthunzi","sequence":"additional","affiliation":[{"name":"University of North Carolina Project, Lilongwe, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Kawalazira","sequence":"additional","affiliation":[{"name":"College of Medicine, Johns Hopkins Research Project, Blantyre, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kusum","family":"Nathoo","sequence":"additional","affiliation":[{"name":"College of Health Sciences, University of Zimbabwe, Avondale, Harare, Zimbabwe"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Bradford","sequence":"additional","affiliation":[{"name":"FHI 360, IMPAACT Operations Center, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Coletti","sequence":"additional","affiliation":[{"name":"FHI 360, IMPAACT Operations Center, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca.","family":"Aweeka","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippa","family":"Musoke","sequence":"additional","affiliation":[{"name":"Makerere University\u2014Johns Hopkins University Research Collaboration, Kampala, Uganda"},{"name":"Department of Paediatrics and Child Health, College of Health Sciences, Makerere University, Kampala, Uganda."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,1,12]]},"reference":[{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01.aids.0000302262.51286.a5","article-title":"Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a meta-analysis.","volume":"22","year":"2008","journal-title":"AIDS"},{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/01.qai.0000226334.34717.dc","article-title":"Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial.","volume":"42","author":"Walker","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.trstmh.2008.10.029","article-title":"HIV prevalence and mortality among children undergoing treatment for severe acute malnutrition in sub-Saharan Africa: a systematic review and meta-analysis.","volume":"103","author":"Fergusson","year":"2009","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1089\/aid.2016.0261","article-title":"Malnutrition in HIV-infected children is an indicator of severe disease with an impaired response to antiretroviral therapy.","volume":"34","author":"Muenchhoff","year":"2018","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"suppl 1","key":"R6-20250615","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2165\/00003088-198900171-00006","article-title":"Drug metabolism and pharmacokinetics in malnourished children.","volume":"17","author":"Krishnaswamy","year":"1989","journal-title":"Clin Pharmacokinet"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/0016-5085(88)90668-3","article-title":"Decreased gastric acid secretion and bacterial colonization of the stomach in severely malnourished Bangladeshi children.","volume":"94","author":"Gilman","year":"1988","journal-title":"Gastroenterology"},{"key":"R8-20250615","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00003088-200847020-00001","article-title":"Drug interactions between HIV protease inhibitors and acid-reducing agents.","volume":"47","author":"Falcon","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"R16-20250615","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/FTD.0b013e31828f5088","article-title":"Clinical pharmacology quality assurance program: models for longitudinal analysis of antiretroviral proficiency testing for international laboratories.","volume":"35","author":"DiFrancesco","year":"2013","journal-title":"Ther Drug Monit"},{"key":"R17-20250615","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1097\/INF.0000000000000603","article-title":"The effect of malnutrition on the pharmacokinetics and virologic outcomes of lopinavir, efavirenz and nevirapine in food insecure HIV-infected children in Tororo, Uganda.","volume":"34","author":"Bartelink","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"R18-20250615","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/jcph.1293","article-title":"Population pharmacokinetics of lopinavir\/ritonavir: changes across formulations and human development from infancy through adulthood.","volume":"58","author":"Yang","year":"2018","journal-title":"J Clin Pharmacol"},{"key":"R19-20250615","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/clpt.2011.225","article-title":"Pharmacokinetics of antiretroviral drug varies with formulation in the target population of children with HIV-1.","volume":"91","author":"Kasirye","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"R20-20250615","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3851\/IMP1931","article-title":"Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine\/lamivudine\/nevirapine in HIV-infected children.","volume":"16","author":"Chokephaibulkit","year":"2011","journal-title":"Antivir Ther"},{"key":"R21-20250615","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/INF.0000000000000143","article-title":"Pharmacokinetics of zidovudine dosed twice daily according to World Health Organization weight bands in Ugandan HIV-infected children.","volume":"33","author":"Fillekes","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R22-20250615","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1021\/js960085v","article-title":"Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH.","volume":"86","author":"Charman","year":"1997","journal-title":"J Pharm Sci"},{"key":"R23-20250615","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1471-2431-13-132","article-title":"Adherence to antiretroviral therapy and associated factors among HIV infected children in Ethiopia: unannounced home-based pill count versus caregivers\u2019 report.","volume":"13","author":"Biressaw","year":"2013","journal-title":"BMC Pediatr"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003055","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T12:05:20Z","timestamp":1749989120000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,12]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003055","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,12]]}}}